Recurrent B-Cell Tumor
1 clinical trials · Condition
◉ Watch Recurrent B-Cell Tumor
| Record | Firm | Date |
|---|---|---|
| Immunotherapy Using Autologous T Cell-Engineered With CD19-specific Chimeric Antigen Receptor for the Treatment of Recurrent /Refractory B Cell Leukemia (NCT02644655) | Second Military Medical University | 2015-09-01 |
Track Recurrent B-Cell Tumor automatically
Every clearance here is in the API, with alerts when new ones post.